tiprankstipranks
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)
:9989
Hong Kong Market
9989
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:9989 full AI Analyst Report?

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Ratios

2 Followers

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Ratios

HK:9989's free cash flow for Q1 2026 was ¥0.34. For the 2026 fiscal year, HK:9989's free cash flow was decreased by ¥ and operating cash flow was ¥0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.15 2.31 2.60 2.13 2.22
Quick Ratio
 1.21 1.19 1.14 0.79 0.99
Cash Ratio
 0.40 0.34 0.46 0.37 0.38
Solvency Ratio
 0.19 0.16 0.19 -0.06 0.12
Operating Cash Flow Ratio
 0.35 0.43 0.59 0.08 -0.14
Short-Term Operating Cash Flow Coverage
 0.57 0.97 1.19 0.21 -0.32
Net Current Asset Value
¥ 4.80B¥ 4.60B¥ 4.48B¥ 3.39B¥ 3.98B
Leverage Ratios
Debt-to-Assets Ratio
 0.16 0.13 0.17 0.20 0.31
Debt-to-Equity Ratio
 0.23 0.18 0.25 0.32 0.53
Debt-to-Capital Ratio
 0.19 0.15 0.20 0.24 0.34
Long-Term Debt-to-Capital Ratio
 <0.01 0.02 0.08 0.13 0.16
Financial Leverage Ratio
 1.40 1.38 1.43 1.61 1.69
Debt Service Coverage Ratio
 0.34 0.43 0.55 -0.10 0.48
Interest Coverage Ratio
 10.71 8.90 5.25 -1.07 4.83
Debt to Market Cap
 0.20 0.30 0.54 0.78 0.68
Interest Debt Per Share
 1.94 1.49 2.13 2.73 4.57
Net Debt to EBITDA
 0.99 0.90 1.08 -5.82 3.15
Profitability Margins
Gross Profit Margin
33.54%31.81%33.26%33.06%32.61%
EBIT Margin
9.12%8.65%16.43%-12.95%14.88%
EBITDA Margin
18.66%15.45%22.70%-6.09%19.17%
Operating Profit Margin
12.27%11.61%14.04%-4.37%15.86%
Pretax Profit Margin
7.97%7.34%13.75%-17.05%11.59%
Net Profit Margin
7.03%6.38%12.25%-14.38%10.16%
Continuous Operations Profit Margin
6.90%6.25%11.83%-14.73%9.99%
Net Income Per EBT
88.14%86.88%89.05%84.37%87.66%
EBT Per EBIT
64.98%63.25%97.97%389.87%73.11%
Return on Assets (ROA)
2.24%2.10%3.73%-4.08%3.49%
Return on Equity (ROE)
3.12%2.90%5.32%-6.57%5.91%
Return on Capital Employed (ROCE)
5.29%5.02%5.43%-1.67%7.45%
Return on Invested Capital (ROIC)
3.76%3.75%4.12%-1.28%5.55%
Return on Tangible Assets
2.64%2.50%4.44%-4.78%4.07%
Earnings Yield
2.38%5.09%11.85%-16.46%10.28%
Efficiency Ratios
Receivables Turnover
 3.91 3.90 4.13 7.27 4.07
Payables Turnover
 12.46 14.53 11.76 12.06 11.29
Inventory Turnover
 0.86 0.84 0.65 0.55 0.71
Fixed Asset Turnover
 2.34 2.29 1.99 2.07 2.89
Asset Turnover
 0.32 0.33 0.30 0.28 0.34
Working Capital Turnover Ratio
 1.05 0.99 0.92 0.88 1.12
Cash Conversion Cycle
 488.16 502.98 615.88 686.23 575.16
Days of Sales Outstanding
 93.27 93.67 88.32 50.22 89.77
Days of Inventory Outstanding
 424.18 434.43 558.59 666.27 517.72
Days of Payables Outstanding
 29.28 25.12 31.04 30.26 32.33
Operating Cycle
 517.45 528.10 646.92 716.50 607.49
Cash Flow Ratios
Operating Cash Flow Per Share
 1.06 1.17 1.50 0.27 -0.52
Free Cash Flow Per Share
 0.99 1.08 1.36 -0.03 -0.67
CapEx Per Share
 0.07 0.08 0.14 0.30 0.15
Free Cash Flow to Operating Cash Flow
 0.93 0.93 0.91 -0.12 1.29
Dividend Paid and CapEx Coverage Ratio
 10.45 3.10 6.05 0.46 -1.60
Capital Expenditure Coverage Ratio
 15.34 14.14 10.82 0.90 -3.40
Operating Cash Flow Coverage Ratio
 0.56 0.81 0.74 0.11 -0.12
Operating Cash Flow to Sales Ratio
 0.29 0.31 0.42 0.07 -0.11
Free Cash Flow Yield
10.71%23.18%36.49%-0.98%-13.84%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 41.93 19.65 8.44 -6.08 9.72
Price-to-Sales (P/S) Ratio
 2.50 1.25 1.03 0.87 0.99
Price-to-Book (P/B) Ratio
 1.31 0.57 0.45 0.40 0.57
Price-to-Free Cash Flow (P/FCF) Ratio
 9.34 4.31 2.74 -102.01 -7.23
Price-to-Operating Cash Flow Ratio
 10.27 4.01 2.49 11.95 -9.35
Price-to-Earnings Growth (PEG) Ratio
 -0.99 -0.43 -0.05 0.03 0.05
Price-to-Fair Value
 1.31 0.57 0.45 0.40 0.57
Enterprise Value Multiple
 14.41 9.01 5.63 -20.18 8.30
Enterprise Value
 14.56B 7.63B 6.75B 6.69B 11.40B
EV to EBITDA
 14.41 9.01 5.63 -20.18 8.30
EV to Sales
 2.69 1.39 1.28 1.23 1.59
EV to Free Cash Flow
 10.03 4.79 3.39 -143.36 -11.64
EV to Operating Cash Flow
 9.37 4.45 3.07 16.80 -15.07
Tangible Book Value Per Share
 6.58 6.44 6.43 6.25 6.46
Shareholders’ Equity Per Share
 8.30 8.20 8.28 8.12 8.39
Tax and Other Ratios
Effective Tax Rate
 0.13 0.15 0.14 0.14 0.14
Revenue Per Share
 3.69 3.73 3.60 3.71 4.88
Net Income Per Share
 0.26 0.24 0.44 -0.53 0.50
Tax Burden
 0.88 0.87 0.89 0.84 0.88
Interest Burden
 0.87 0.85 0.84 1.32 0.78
Research & Development to Revenue
 0.04 0.04 0.04 0.03 0.04
SG&A to Revenue
 0.09 0.09 0.09 0.03 0.02
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 11.79 5.00 3.51 -0.50 -1.06
Currency in CNY